Jonathan Fuchs, MD, MPH
Dr. Fuchs currently directs government and industry-supported clinical trials of preventive HIV vaccines. He also leads the San Francisco site participating in a phase III trial of HSV-2 prophylaxis to prevent HIV acquisition among HIV negative men and women. His research interests include testing biomedical interventions to prevent HIV including vaccines, treatment of sexually transmitted infections, and rectal microbicides. He is also focused on characterizing MSM populations outside of the US, particularly in sub-Saharan Africa, to encourage indigenous, targeted prevention efforts. As the co-Chair of the NIH-sponsored HIV Vaccine Trials Network Training and Education Committee, Dr. Fuchs has been involved in creating novel web-based training to support the implementation of HIV clinical trials in developing world settings. He is the PI the OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation; octave.bio-med.ch) and is interested in evaluating the efficacy of conventional and web-based approaches to improve trainee skills.